Other highlights in the May 17 JNCI

May 16, 2006

Statin Use Does Not Cause Breast Cancer

Postmenopausal women who use statins have the same risk of breast cancer as those who do not, according to a new study.

Using a group of 156,351 women from the Women's Health Initiative study, Jane A. Cauley, Dr.P.H., from the University of Pittsburgh, and colleagues examined use of cholesterol-lowering drugs called statins and risk of invasive breast cancer. After an average follow-up of 6.7 years, they identified 4,383 invasive breast cancers.

The authors found that when all statins were considered together, statin use did not affect a person's risk of invasive breast cancer. Use of a type of statins, known as hydrophobic statins, was associated with an 18% decreased risk of breast cancer.

"Future studies of statins and breast cancer should assess associations with individual statins or statin categories because [statin] class differences may exist," the authors write.

Contact: Jim Swyers, 412-586-9773, swyersjp@upmc.edu

Mathematical Graph Can Accurately Predict Prostate Cancer Recurrence a Decade After Prostate Removal

A graph used to calculate prostate cancer recurrence, called a nomogram, makes accurate predictions about recurrence up to ten years after removal of the prostate gland, according to a new study.

Michael W. Kattan, Ph.D., of the Cleveland Clinic Foundation in Ohio, and colleagues tested a nomogram's ability to predict prostate cancer recurrence in 1,545 patients treated for prostate cancer. The results showed that the model slightly overpredicted that patients would not have recurring cancer (at 8 years, the model predicted recurrence free progression of 70-85%, versus 57-72% observed), but on the whole was an accurate predictor for prostate cancer recurrence.

Contact: Raquel Santiago, 216-444-4235, santiar@ccf.org

Hormones Used To Combat Anemia May Be Harmful

Erythropoietin, a hormone used to counter anemia, may increase a patient's risk of developing blood clots when given with chemotherapy drugs.

Julia Bohlius, M.D., of the University Hospital of Cologne in Germany, and colleagues reviewed the results of 57 trials between 1985 and April 2005 that examined the effects of medications epoetin alfa and beta and darbepoetin alfa. They observed that epoetin and darbepoetin reduced the need for red blood cell transfusions and improved hematologic response. But use of the drugs with thrombogenic chemotherapy increased the risk of thrombo-embolic events, which can have harmful effects including death. The authors suggest cancer patients using the drug combination or at high risk for blood clotting should exercise caution as the treatments are potentially harmful.

Contact: Julia Bohlius, 49-221-478-5933, Julia.Bohlius@uk-koeln.de

Also in the May 17 JNCI:
Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage. Visit the Journal online at http://jncicancerspectrum.oxfordjournals.org/.

Journal of the National Cancer Institute

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.